The cyclic AMP signaling pathway: Exploring targets for successful drug discovery (Review)
Phosphodiesterases Catalyze Hydrolysis of cAMP-bound to Regulatory Subunit of Protein Kinase A and Mediate Signal Termination - ScienceDirect
Frontiers | The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
PDE-4/cAMP/CREB cascade in cognition: bidirectional regulation of... | Download Scientific Diagram
Different phosphodiesterases (PDEs) regulate distinct phosphoproteomes during cAMP signaling | PNAS
IJMS | Free Full-Text | Therapeutic Implications for PDE2 and cGMP/cAMP Mediated Crosstalk in Cardiovascular Diseases | HTML
Phosphodiesterases Catalyze Hydrolysis of cAMP-bound to Regulatory Subunit of Protein Kinase A and Mediate Signal Termination* - Molecular & Cellular Proteomics
Phosphodiesterase 3 - Wikipedia
Phosphodiesterases as therapeutic targets for respiratory diseases - ScienceDirect
Phosphodiesterase - Wikipedia
Role of phosphodiesterases in the pathophysiology of neurodevelopmental disorders | Molecular Psychiatry
Channeling of cAMP in PDE-PKA Complexes Promotes Signal Adaptation
IJMS | Free Full-Text | Phosphodiesterases and Compartmentation of cAMP and cGMP Signaling in Regulation of Cardiac Contractility in Normal and Failing Hearts | HTML
The Role of Cyclic 3'-5' Adenosine Monophosphate (cAMP) in Differentiated and Trans-Differentiated Vascular Smooth Muscle Cells | IntechOpen
Phosphodiesterases in endocrine physiology and disease in: European Journal of Endocrinology Volume 165 Issue 2 (2011)
Re: How and why does caffine effect the pulse rate of a person
IJMS | Free Full-Text | Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19?
Targeting cAMP Signaling for the Treatment of Inflammatory Diseases of the Skin - JDDonline - Journal of Drugs in Dermatology
Proposed model of phosphodiesterase (PDE) and protein kinase (PK)... | Download Scientific Diagram
Dart NeuroScience LLC -- Internal Research -- Memory Enhancers
CV Pharmacology | Phosphodiesterase Inhibitors
Concerted Regulation of cGMP and cAMP Phosphodiesterases in Early Cardiac Hypertrophy Induced by Angiotensin II | PLOS ONE
Update on Phosphodiesterase (PDE) Isoenzymes as Pharmacologic Targets in Urology: Present and Future - European Urology
CV Pharmacology | Phosphodiesterase Inhibitors
Overview of PDEs and Their Regulation | Circulation Research
Frontiers | Phosphodiesterases and cAMP Pathway in Pituitary Diseases
Overview of PDEs and Their Regulation | Circulation Research
PDEs as drug targets – Mironid
